APEX Pharma Selects IQVIA Orchestrated Customer Engagement (OCE) for Egyptian and Saudi markets
IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced that APEX Pharma, a leading pharmaceutical company in Egypt, has selected IQVIA Technologies’ Orchestrated Customer Engagement (OCE) platform for deployment in the Egyptian market, with future plans to deploy it to the Saudi market.
“We are very pleased to be working with IQVIA on this project,” said Dr. Magdy Elba, Chairman and CEO for APEX Pharma. “The COVID-19 pandemic has accelerated the need to reconsider how customer relationships are managed in the pharmaceutical sector. In addition, we consider change as an opportunity to grow and unleash the courage, collaboration and creativity of our team members. OCE will enable APEX Pharma to adopt new ways of interacting with Health Care Providers (HCPs) in order to continue providing them with required information and building an exceptional relationship with our customers based on care, respect and trust to achieve the needed results.”
IQVIA Technologies’ OCE for advanced customer engagement breaks down silos by seamlessly connecting sales, account management, marketing and other functions to enhance the customer experience, strengthen relationships and drive performance. OCE is built on best-in-class industry platforms, including Salesforce, MuleSoft, Heroku and Box. With unique capabilities, such as predictive analytics and machine learning providing AI-enabled recommendations, fluid integration with other data and applications to deliver smarter, coordinated engagements with healthcare professionals.
“IQVIA has worked closely with Apex pharma for several years now. We are proud to facilitate the digital transformation of the APEX Pharma commercial model and support its goal to deliver exceptional customer engagement and value-added services to HCPs in Egypt and, soon, to Saudi Arabia,” said Mohamed Omar, Country manager of Egypt, IQVIA. “With ongoing COVID-19 pandemic, customer engagement models are evolving and OCE will support Apex’s ambition to transform customer engagement to meet those changes and maintain customer loyalty.”
APEX Pharma joins more than 140 other life sciences customers that have selected IQVIA OCE’s innovative solutions to address market momentum and the need for innovative platforms to advance customer engagement.
About IQVIA
IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries.
IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.
About APEX Pharma
APEX Pharma is a marketing-driven organization started operation in January 1997 & succeeded to build a model of an ethical generic pharmaceutical company, moving from one achievement to another, seeking to reach the optimum destination in the pharmaceutical industry in Egypt and MENA region. For more information about APEX Pharma, please visit www.apexpharmaeg.com